Recent Advances to Watch in Women’s Health

Be it a temporary illness or chronic disease, women health issues have always been neglected in most parts of the world, particularly in some under-developed regions. Women undergo a lot of life changing phases during their lifetime that hamper their physical, as well as psychological, health. Such changes can potentially affect the overall health of women causing various minor or major ailments. Some of the common health issues faced by women include Polycystic Ovary Syndrome (PCOS), endometriosis, postmenopausal osteoporosis, and several others.

Postmenopausal Osteoporosis Dominated the Application Segment

Infertility, Ovary Syndrome (PCOS), menopause, endometriosis, postmenopausal osteoporosis, and contraceptives are the major application areas for women’s health. Postmenopausal osteoporosis led the global application segment for women’s health in 2016. This growth was due to the presence of large number of women with postmenopausal osteoporosis along with the easy availability of cost-effective treatments for the same.

In addition, rising number of ongoing research and development in the field is predicted to boost the segment expansion over the forecast years i.e., from 2017 to 2025. In the recent past, FDA approved TYMLOS (abaloparatide), a bone building agent for the treatment of postmenopausal osteoporosis, by Radius Health. The newly approved TYMLOS injection reduces the risks of nonvertebral and vertebral fractures.

Contraceptives application is anticipated to be the fastest-growing segment over the next few years. This rapid expansion can be attributed to constant advent of novel and highly developed contraceptive methods and increased awareness levels among people regarding family planning. Furthermore, supportive government rules and regulations in developed regions such as United States along with the rising awareness regarding various contraceptive methods are also likely to augment the segment growth.

Market Overview

Based on the findings of a report published by Grand View Research, Inc.; the global women’s health market was estimated at USD 36.5 billion in 2016 and is further expected to reach at USD 51.3 billion by 2025. The global market is also predicted to register a healthy growth rate of 3.9 % during the forecast years. Key factors driving this market include the rising female population base, supportive government policies, and introduction of new drugs for women’s health. Pfizer, Inc.; Merck & Co., Inc.; Teva Pharmaceutical Industries Ltd.; Ferring B.V.; and Agile Therapeutics, Inc. are some of the prominent companies in the global market for women’s health.

In-Depth Research Report On Women’s Health Market:

https://www.grandviewresearch.com/industry-analysis/womens-health-market